Metoject 22.5 mg/0.45ml (Methotrexate PFS) 22.5 mg/0.45ml

Metoject 22.5 mg/0.45ml PFS contains methotrexate, a prescription medication used for immune system modulation. This pre-filled syringe form is designed for subcutaneous injection. Always follow healthcare provider guidance when using methotrexate PFS. Short-term storage at room temperature is typically acceptable.

Strength

22.5 mg/0.45ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Gebro pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methotrexate PFS like Metoject 22.5 mg/0.45ml is commonly used to manage inflammatory conditions such as rheumatoid arthritis and psoriasis. It may also be prescribed for certain types of cancer when directed by a physician. Patients often ask what is methotrexate used for in autoimmune disorders.

Side Effects

Methotrexate PFS may help reduce inflammation and slow disease progression in immune-related conditions. Users often report improved mobility and reduced joint pain over time. Effects vary by individual and treatment duration. Regular monitoring is typically recommended during therapy.

Precautions & Warnings

Keep Metoject 22.5 mg/0.45ml PFS out of reach of children and pets. Do not use if the syringe is damaged or the solution appears discolored. Store at room temperature away from moisture and heat. Always dispose of used syringes in a sharps container.

Avoid Interactions

Methotrexate PFS may interact with alcohol, certain antibiotics, and NSAIDs. Supplements like folic acid may be recommended to reduce side effects. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions can affect how methotrexate works.

Frequently Asked Questions

Methotrexate is commonly prescribed to reduce inflammation and slow disease progression in conditions like rheumatoid arthritis and psoriasis.

Metoject is a pre-filled syringe designed for subcutaneous injection; follow your healthcare provider's instructions for proper use.

Alcohol may increase the risk of side effects; consult your healthcare provider before consuming alcohol during treatment.

Contact your healthcare provider for guidance if you miss a dose; do not take a double dose without medical advice.

Store at room temperature away from moisture and heat; keep out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.